平阳霉素联合地塞米松治疗颌面部血管瘤的临床观察
【摘要】 目的 探讨平阳霉素(PYM)地塞米松(DXM)与混合注射治疗颌面部海绵状血管瘤的疗效及其优点。方法 收集2002年11月至2008年3月,用PYM和DXM混合注射治疗颌面部海绵状血管瘤病例227例,观察平阳霉素治疗颌面部血管瘤的临床效果。结果 经6~24个月的随访观察,总有效率为100%,尤其是对海绵状血管瘤治疗效果最为满意,且不良反应较少。结论 PYM、DXM混合注射治疗颌面部海绵状血管瘤,具有疗程短、疗效高、不良反应小等优点,是一种安全、可靠、简便、易行的方法。【关键词】 平阳霉素;地塞米松;颌面部血管瘤
Pingyangmycin dexamethasone treatment of maxillofacial hemangiomas clinical observation
MENG Kang,HUANG Wen-bo,WANG He-wei.
Nanyang City CenterHospital, Nanyang, Henan Province 473009,China
【Abstract】 Objective Sum pingyangmycin (PYM) dexamethasone (DXM) mixed injection maxillofacial cavernous hemangioma and its efficacy advantages . Methods Collection from November 2002 to March 2008, with PYM and mixed DXM injection maxillofacial cavernous hemangioma 227cases were observed treatment Pingyangmycin maxillofacial hemangioma clinical results. Results 2a by 6 m to the follow-up, with a total effective rate was 100%, especially for the treatment of cavernous hemangioma of the most satisfied with the results and fewer side effects.Conclusion PYM, DXM mixed injection maxillofacial cavernous hemangioma, with a short course of treatment, efficacy, adverse reactions such as small advantages, is a safe, reliable, simple and easy. ......
您现在查看是摘要页,全文长 5193 字符。